Mitral valve

TCT 2023 | CLASP IID Study 1-Year Results: PASCAL vs. MITRACLIP for Degenerative Mitral Regurgitation

The negative impact of mitral regurgitation (MR) on patient mortality, morbidity, and quality of life is widely...

TCT 2023 | TRILUMINATE Trial: Health Status after TriClip

Severe tricuspid regurgitation (TR) has been associated with higher mortality, increased risk of hospitalization for cardiac failure...

TCT 2023 | EXPAND G4

The EXPAND G4 is a prospective multicenter single arm study on real life patients.  It included a total...

MITRAL Trial, Results at 5 Years

Repeat mitral valve repair has been associated with increased mortality. Transcatheter mitral valve repair has surged as...

TRILUMINATE Two Years In: Encouraging Results

Tricuspid valve regurgitation is more common than one might think. It often stems from left valve disease...

Degenerative Mitral Regurgitation: Impact on Post-Procedural Gradient

Primary or degenerative mitral regurgitation (MR) occurs frequently. Even though surgery continues to be the standard treatment...

SOLACI-SBHCI 2023 | Mitral Valve Interventions beyond the TEER Era: Time to Re-Evaluate Innovation Priorities?- Dr. Eberhard Grube

Read the most outstanding articles from SOLACI-SBHCI 2023 Congress. In this case, check the presentation by Dr. Eberhard...

Mitral Valve Edge to Edge Repair for Papillary Muscle Rupture after Acute Myocardial Infarction

With an approximate incidence of 0.05% to 0.25%, post-acute myocardial infarction (AMI) mitral valve failure caused by...